These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7870081

  • 1. Inhalation of benzene leads to an increase in the mutant frequencies of a lacI transgene in lung and spleen tissues of mice.
    Mullin AH, Rando R, Esmundo F, Mullin DA.
    Mutat Res; 1995 Mar; 327(1-2):121-9. PubMed ID: 7870081
    [Abstract] [Full Text] [Related]

  • 2. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I).
    Rogers BJ, Provost GS, Young RR, Putman DL, Short JM.
    Mutat Res; 1995 Mar; 327(1-2):57-66. PubMed ID: 7870099
    [Abstract] [Full Text] [Related]

  • 3. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM, Harbach PR, Mattes WB, Aaron CS.
    Environ Mol Mutagen; 1999 Mar; 33(3):249-56. PubMed ID: 10334627
    [Abstract] [Full Text] [Related]

  • 4. Interlaboratory comparison: liver spontaneous mutant frequency from lambda/lacI transgenic mice (Big Blue) (II).
    Young RR, Rogers BJ, Provost GS, Short JM, Putman DL.
    Mutat Res; 1995 Mar; 327(1-2):67-73. PubMed ID: 7870100
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
    Sisk SC, Pluta LJ, Meyer KG, Wong BC, Recio L.
    Mutat Res; 1997 Jul 14; 391(3):153-64. PubMed ID: 9268040
    [Abstract] [Full Text] [Related]

  • 6. Transgenic lambda/lacI mutagenicity assay: statistical determination of sample size.
    Callahan JD, Short JM.
    Mutat Res; 1995 Mar 14; 327(1-2):201-8. PubMed ID: 7870088
    [Abstract] [Full Text] [Related]

  • 7. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L, Saranko CJ, Steen AM.
    Res Rep Health Eff Inst; 2000 Mar 14; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR, Gorelick NJ, Andrews JL, de Boer JG, Glickman BW.
    Environ Mol Mutagen; 1996 Mar 14; 28(4):385-92. PubMed ID: 8991067
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ, Kort KL, Miller JE, Marino DR, Skopek TR.
    Mutat Res; 1998 Oct 12; 421(1):121-36. PubMed ID: 9748534
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts.
    Watson DE, Cunningham ML, Tindall KR.
    Mutagenesis; 1998 Sep 12; 13(5):487-97. PubMed ID: 9800194
    [Abstract] [Full Text] [Related]

  • 16. Spontaneous mutations in lacI-containing lambda lysogens derived from transgenic mice: the observed patterns differ in liver and spleen.
    Knöll A, Jacobson DP, Kretz PL, Lundberg KS, Short JM, Sommer SS.
    Mutat Res; 1994 Nov 01; 311(1):57-67. PubMed ID: 7526175
    [Abstract] [Full Text] [Related]

  • 17. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ, Shane BS, Tindall KR, Cunningham ML.
    Carcinogenesis; 1995 Oct 01; 16(10):2429-33. PubMed ID: 7586147
    [Abstract] [Full Text] [Related]

  • 18. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
    Knöll A, Jacobson DP, Nishino H, Kretz PL, Short JM, Sommer SS.
    Mutat Res; 1996 Jun 10; 352(1-2):9-22. PubMed ID: 8676922
    [Abstract] [Full Text] [Related]

  • 19. Comparison of hprt and lacI mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminofluorene-treated Big Blue rats.
    Chen T, Mittelstaedt RA, Aidoo A, Hamilton LP, Beland FA, Casciano DA, Heflich RH.
    Environ Mol Mutagen; 2001 Jun 10; 37(3):195-202. PubMed ID: 11317337
    [Abstract] [Full Text] [Related]

  • 20. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
    Walker VE, Sisk SC, Upton PB, Wong BA, Recio L.
    Mutat Res; 1997 Aug 14; 392(3):211-22. PubMed ID: 9294020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.